000 01755 a2200409 4500
005 20250516043408.0
264 0 _c20111019
008 201110s 0 0 eng d
022 _a1083-351X
024 7 _a10.1074/jbc.M110.197665
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTian, Xiaobing
245 0 0 _aModulation of CCAAT/enhancer binding protein homologous protein (CHOP)-dependent DR5 expression by nelfinavir sensitizes glioblastoma multiforme cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
_h[electronic resource]
260 _bThe Journal of biological chemistry
_cAug 2011
300 _a29408-29416 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aActivating Transcription Factor 4
_xgenetics
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCell Line, Tumor
650 0 4 _aGene Expression Regulation, Neoplastic
_xdrug effects
650 0 4 _aGlioblastoma
_xdrug therapy
650 0 4 _aHIV Protease Inhibitors
_xpharmacology
650 0 4 _aHumans
650 0 4 _aNelfinavir
_xpharmacology
650 0 4 _aNeoplasm Proteins
_xgenetics
650 0 4 _aReceptors, TNF-Related Apoptosis-Inducing Ligand
_xbiosynthesis
650 0 4 _aTNF-Related Apoptosis-Inducing Ligand
_xpharmacology
650 0 4 _aTranscription Factor CHOP
_xgenetics
650 0 4 _aUnfolded Protein Response
_xdrug effects
700 1 _aYe, Jiangbin
700 1 _aAlonso-Basanta, Michelle
700 1 _aHahn, Stephen M
700 1 _aKoumenis, Constantinos
700 1 _aDorsey, Jay F
773 0 _tThe Journal of biological chemistry
_gvol. 286
_gno. 33
_gp. 29408-29416
856 4 0 _uhttps://doi.org/10.1074/jbc.M110.197665
_zAvailable from publisher's website
999 _c20951210
_d20951210